Brii Biosciences Public
We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations.
Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice.
Technology:
COVID
Headquarters:
United States
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
2018-01-01
Number Of Exists:
N/A
Last Funding Type:
Venture - Series Unknown
Investors Number:
6
Last Funding Date:
2018-05-24
Employee Number:
N/A
Total Funding:
260000000 USD
Industry:
PharmTech
Investor Type:
N/A